Skip to main content

SSMXF · Sysmex Corporation · Metrics

Track SSMXF — free
$11.35 At close · Oct 13 Play latest call Q2 2027 earnings call transcript
Market Cap
$6.87B
Shares
605.20M
Volume · Oct 13 300 Avg daily vol (8 sessions) 1475

SSMXF metrics

39 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$11.35
Market cap
$6.87B

Price action

23 metrics
Price change (1W)
—
Price change (30D)
—
Price change (3M)
+17.6%
Price change (6M)
—
Price change (YTD)
+14.9%
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
$12.50
52-week low
$8.33
Change from 52-week high
-9.2%
Change from 52-week low
+36.3%
Annualized volatility
—
Annualized volatility (3M)
—
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
—
RSI (14D)
51.6
Price vs SMA 50
-12.7%
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
605.20M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
2.2%
Trailing 12 months
Payout ratio
68.8%
Shareholder yield
—
Dividend / share (TTM)
$0.25
Dividend growth YoY
+8.4%
Dividend growth streak
3
Last ex-dividend
2026-09-29

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-11

Profitability

9 metrics
Gross margin
50.6%
Operating margin
9.7%
Trailing 12 months
Net margin
6.4%
Gross profit (TTM)
$273.56B
Operating profit (TTM)
$52.30B
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
13.4%
Effective tax rate
28.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
-1.7%
Year over year
Net income growth YoY
-33.9%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
+6.8%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-7.3%
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
7.1%
Return on assets
4.7%
Debt / equity
—
Current ratio
3.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
3.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
—
Total assets
—
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
0.3%
Latest settlement · 999+ days to cover
Days to cover
999+
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—